A news implantable device to treat moderate to severe central sleep apnea


eMediNexus    10 October 2017

The US Food and Drug Administration FDA has approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remed 275 System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.